Chronic lymphocytic leukaemia: A-twenty-years experience and problems in Ile-Ife, South-Western Nigeria

African Health Sciences

Volumn 10, Issue 2, 2010, Pages 187-192

  Salawu, L ^a   Bolarinwa, R A ^a   Durosinmi, M A ^a  

^a OBAFEMI AWOLOWO UNIVERSITY TEACHING HOSPITALS COMPLEX   (Nigeria)

Author keywords

CLL; Diagnostic problems; Resource limited setting

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISOLONE; VINCRISTINE;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; BLOOD EXAMINATION; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HEPATOMEGALY; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NIGERIA; PERSONAL EXPERIENCE; PROGNOSIS; RETROSPECTIVE STUDY; SEX RATIO; SPLENOMEGALY; SURVIVAL TIME; THROMBOCYTE COUNT;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; NIGERIA; PLATELET COUNT; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE;

EID: 78049454463     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cmunt E, Michalova K, Sindelarova L Karban J, Zemanova Z, Kurkova S et al Importance of prognostic factors in patients with chronic Blymphocytic leukaemia at the time of diagnosis. Sb Lek 2002; 103: 359-370
2. Gowda A, Byrd JC Use of prognostic factors in risk stratification at diagnosis and time of treatment of patients with chronic lymphocytic leukaemia. Cur Opin Haematol 2006; 13: 266-272
3. Thomas JK. Chronic lymphocytic leukaemia and related disorders. In: Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT [eds] Williams Haematology. 7th Edition. New York. McGraw-Hill. 2006, pp 1343-1383.
4. Brenner H, Gondos A, Pulte D. Trends in longterm survival of patients with chronic lymphocytic leukaemia from the 1980s to the early 21st century. Blood. 2008; 111: 4916-4921
5. Thurmes P, Call T, Slager S, Zent C, Jenkins G, Schwager S, et al. Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2008; 49: 49-56.
6. Pamuk ON, Pamuk GE, Soysal T, Ongören S, Balar Z, Ferhanodlu B, et al. Chronic lymphocytic leukemia in Turkey: experience of a single center in Istanbul. South Med J. 2004; 97: 240-245
7. Molica S. Sex differences in incidence and outcome of chronic lymphocytic leukaemia patients. Leuk Lymphoma. 2006; 47: 1477-1480
8. de Faria JR, de Oliveira JSR, de Faria RMD, Silva MRR, Goihman S, Yamamoto M, et al. Prognosis related to staging systems for chronic lymphocytic leukaemia. Sao Paulo Med J. 2000; 118: 83-88
9. Catovsky D, Fooks J, Richards S. Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CCL 1 trial. MRC Working Party on Leukaemia in Adults. Cr J Haematolo 1989; 72:141-149
10. Sriphatphiriyakun T, Auewarakul CU. Clinical presentation and outcome of Thai patients with chronic lymphocytic leukaemia: retrospective analysis of 184 cases. Asian Pac J Allergy immunol 2005; 23: 197-203
11. Montserrat E, Rozman C. Chronic lymphocytic leukaemia: prognostic factors and natural history. Baillieres Clin Haematol 1993; 6: 849-866
12. Chen PM, Lin SH, Fan SF, Chiou TJ, Hsieh RK, Yu IT, et al. Genotypic characterisation and multivariate survival analysis of chronic lymphocytic leukaemia in Taiwan. Acta Haematol. 1997; 97: 196-204
13. De Rossi G, Granati L, Girelli G, Gandolo G, Perrone P, Martelli M et al. Prognostic value of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukaemia Jumori 1991; 77: 100-104
14. Koller C, Bekele BN, Zhou X, Park C, Estrov Z, O'Brien S, et al Plasma thrombopoietin compared with immunoglobulin heavy-chain mutation status as a predictor of survival in chronic lymphocytic leukaemia Blood 2006; 108: 1001-1006
15. Catovsky D. Chronic lymphocytic leukaemia and other B cell disorders. In: Hoffbrand AV, Catovsky D, Tuddenham TGD (ed) Postgraduate Haematology 5th ed. Blackwell Publishing, London. 2005; Pp 619-643
16. Mauro FR, Fao R, Cerretti R, Giannarelli D, Coluzzi S, Mandelli F, et al. Anaemia in chronic lymphocytic leukaemia: clinical, therapeutic, and prognostic features Blood 2000; 95: 2786-2792
17. Zent CS, Ding W, Schwager SM, Reinalder MS, Hoyer JD, Jelinek DF. The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma Br J Haematol 2008; 141: 615-621
18. Byrne JL, Russell NH. Haemopoietic growth factors. In: Hoffbrand AV, Catovsky D, Tuddenham TGD (ed) Postgraduate Haematology 5th ed. Blackwell Publishing, London. 2005; Pp 303-317
19. Salawu L, Durosinmi MA. Myelomatosis: Clinical and laboratory features in Nigerians. West African Journal of Medicine. 2005; 24: 54-57
20. Durosinmi MA, Adediran IA. Cancer management under structural adjustment programme (SAP): Experience in Ile-Ife; Nigeria. Nigerian Medical Journal. 1993; 25: 92-96